Litigation

Recent Posts

Hunter Shkolnik Of Rheingold Valet Moves To Napoli Bern Ripka LLP
Posted on 4 Aug 2011 by LexisNexis Litigation Resource Community Staff

NEW YORK - After more than 15 years as a senior partner in the New York personal injury firm Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP, Hunter Shkolnik has joined Napoli Bern Ripka LLP as a senior partner of the firm, which is now known... Read More

Tags: New York lawyers , Napoli Bern Ripka , medical device , New York law firms , drug , Litigation , Rheingold Valet Rheingold Shkolnik & McCartney , Hunter Shkolnik

Federal Food, Drug, And Cosmetic Act Did Not Preclude Lanham Act Challenge That Asserted That Labeling, Marketing, And Advertising Was Misleading
Posted on 1 Jul 2014 by LexisNexis Legal Newsroom Staff

On June 12, 2014, the United States Supreme Court decided the case of POM Wonderful LLC v. Coca-Cola Co., 189 L. Ed. 2d 141 (U.S. 2014) . POM Wonderful, LLC (POM) filed its initial action against Coca-Cola asserting that the labeling, marketing, and advertising... Read More

Tags: Federal Food , Advertising , POM , POM Wonderful , and Cosmetic Act , LLC , California , POM Wonderful LLC v. Coca-Cola Co. , drug , Marketing , FDCA , Litigation , Coca-Cola , Ninth Circuit , food law , labeling , U.S. Supreme Court , torts

Virginia Federal Jury Says Woman Didn't Prove Prempro Warnings Were Inadequate
Posted on 3 Dec 2010 by Tom Moylan

ALEXANDRIA, Va. - (Mealey's) A Virginia federal jury on Dec. 3 found that a woman who claimed to have developed breast cancer from taking Wyeth's Prempro hormone replacement therapy drug did not prove that warnings provided to her doctor were... Read More

Tags: menopause , Wyeth , Georgia Torkie-Tork v. Wyeth , progestin , personal injury , drug , product liability , breast cancer , Trial , warnings , estrogen , Litigation , hormone replacement therapy , Prempro , torts , Georgia Torkie-Tork

AstraZeneca Wins Patent Dispute Over Crestor
Posted on 30 Jun 2010 by LexisNexis Litigation Resource Community Staff

NEW YORK - (AP) AstraZeneca Plc said Tuesday it won a patent challenge brought against its blockbuster cholesterol drug Crestor by generic drug developers. The U.S. District Court in Delaware ruled that a key patent on the company's third best-selling... Read More

Tags: cholesterol drug , Mylan Inc. , Par Pharmaceutical , Crestor , AstraZeneca , drug , Teva Pharmaceutical Industries , Patent , Apotex , patent infringement

AstraZeneca Pays $198M To Settle Seroquel Lawsuits
Posted on 9 Aug 2010 by LexisNexis Litigation Resource Community Staff

LONDON - (AP) AstraZeneca PLC says it has paid around $198 million to settle U.S. lawsuits over its antipsychotic drug Seroquel. Full version available to lexis.com subscriber . Read More

Tags: drugs , AstraZeneca , drug , antipsychotic , U.S. Food and Drug Administration , Litigation , Nexium , lawsuit , settle , diabetes , Seroquel